Gedeon Richter To Market HRA Pharma’s Novel Emergency Contraceptive, ellaOne
This article was originally published in The Pink Sheet Daily
Executive Summary
HRA expects to file an NDA for ellaOne in the U.S. by end of year.
You may also be interested in...
Two Deals Bolster Watson's Position In Branded Women's Health Products
Branded drugs may earn only a fraction of Watson's generics, but firm sees overlapping opportunity in urology and women's health care.
Two Deals Bolster Watson's Position In Branded Women's Health Products
Branded drugs may earn only a fraction of Watson's generics, but firm sees overlapping opportunity in urology and women's health care.
HRA Pharma’s Novel Emergency Contraceptive ellaOne Gains EMEA Marketing Approval
HRA plans to educate pharmacists, as well as physicians, about novel emergency contraceptive.